Eli Lilly and Company
Azetidinyloxyphenylpyrrolidine compounds
Last updated:
Abstract:
The invention provides certain azetidinyloxyphenylpyrrolidine compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat overactive bladder. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
3 Sep 2015
Issue date:
22 Sep 2020